Search results for " transplantation."

showing 10 items of 1389 documents

CT evaluation of the renal donor and recipient

2018

Proper pre- and post-transplant diagnostic imaging work-up is fundamental in ensuring a successful outcome for renal transplantation. Despite exposure to ionizing radiation, CT has high spatial resolution and is a widely available and fast imaging technique. CT is performed routinely to delineate the anatomy of the kidney, relevant vasculature, and urinary collecting system in the living donor, to assess the iliac vessels in potential recipients prior to surgery, and to assess early and late-term post-transplant complications. The purpose of this article is to outline the optimal CT protocol and the main reportable findings for both the donor and the recipient diagnostic imaging work-up as …

medicine.medical_specialtyRadiology Nuclear Medicine and ImagingUrinary systemUrologyContrast Mediakidney transplantationliving donorcomplication030230 surgeryKidney030218 nuclear medicine & medical imaging03 medical and health sciencesPostoperative Complications0302 clinical medicinetransplant recipientInternal medicinePreoperative CareLiving DonorsmedicineHigh spatial resolutionMedical imagingHumansComputed tomographyKidney transplantationKidneyRadiological and Ultrasound Technologybusiness.industryGastroenterologyRadiation ExposureHepatologymedicine.diseaseTransplantationContrast mediummedicine.anatomical_structureRadiologyTomography X-Ray Computedbusiness
researchProduct

High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) Has a Significant but Transient Impact on Quality of Life: Lessons Fr…

2011

Abstract Abstract 1989 Objective: High-dose therapy (HDT) and ASCT is the standard of care in a variety of hematologic malignancies. Whereas for some indications a survival advantage for HDT and ASCT has been demonstrated, a benefit only in terms of better progression-free survival has been shown for CLL. Because of this the quality of life (QoL) deserves particular attention. QoL assessment was a major focus of a randomized controlled EBMT-Intergroup trial on the value of HDT compared to observation in first or second remission of CLL (Michallet, Blood, 2011). Methods: 222 patients were enrolled into the study and allocated to either ASCT or observation. In the transplant arm, 72% received…

medicine.medical_specialtyRandomizationIntention-to-treat analysisbusiness.industrymedicine.medical_treatmentChronic lymphocytic leukemiaImmunologyCell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseBiochemistryTransplantationQuality of lifeChronic leukemiaInternal medicineCohortmedicinebusiness
researchProduct

Modulation of hippocampal acetylcholine release after fimbria-fornix lesions and septal transplantation in rats

1997

Abstract Female Long–Evans rats sustained electrolytic lesions of the fimbria and the dorsal fornix causing a partial lesion of the septohippocampal pathway. Two weeks later, the rats received intra-hippocampal grafts of fetal septal cell suspensions. Nine to twelve months later, the release of acetylcholine (ACh) in the hippocampus of sham-operated, lesion-only and grafted rats was measured by microdialysis. The extent of cholinergic (re)innervation was determined by acetylcholinesterase (AChE) staining and densitometry. In both lesion-only and grafted rats, the ratio of ACh release to AChE staining intensity was increased as compared to sham-operated rats, indicating a loss of endogenous …

medicine.medical_specialtySciences du Vivant [q-bio]/Neurosciences [q-bio.NC]Microdialysis[SDV]Life Sciences [q-bio][SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyScopolamineMuscarinic AntagonistsHippocampal formationBiologySerotonergicHippocampus03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineNeural PathwaysmedicineAnimalsBrain Tissue TransplantationCholinergic neuronNeurotransmitterComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciences8-Hydroxy-2-(di-n-propylamino)tetralinGeneral NeuroscienceFornixMuscarinic antagonistRats Inbred StrainsAcetylcholineRatsEndocrinologychemistryCholinergic FibersAnesthesiaReceptors SerotoninCholinergicRaphe NucleiFemaleSeptal Nuclei[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Receptors Serotonin 5-HT1030217 neurology & neurosurgeryAcetylcholinemedicine.drug
researchProduct

The addition of simvastatin administration to cold storage solution of explanted whole liver grafts for facing ischemia/reperfusion injury in an area…

2018

Abstract Background Liver transplantation is the best treatment for end-stage liver disease. The interruption of the blood supply to the donor liver during cold storage damages the liver, affecting how well the liver will function after transplant. The drug Simvastatin may help to protect donor livers against this damage and improve outcomes for transplant recipients. The aim of this study is to evaluate the benefits of treating the donor liver with Simvastatin compared with the standard transplant procedure. Patient and methods We propose a prospective, double-blinded, randomized phase 2 study of 2 parallel groups of eligible adult patients. We will compare 3-month, 6-month, and 12-month g…

medicine.medical_specialtySimvastatinmedicine.medical_treatmentlcsh:SurgeryCold storageIschemia/reperfusion injury030230 surgeryLiver transplantationDonor after brain deathPlaceboProtective Agents03 medical and health sciencesLiver diseaseStudy Protocol0302 clinical medicineDouble-Blind MethodDonor after brain death; Ischemia/reperfusion injury; Liver transplantation; SimvastatinMedicineHumansProspective StudiesLiver transplantationbusiness.industrylcsh:RD1-811General Medicinemedicine.diseaseSurgeryTransplantationFatty LiverRegimenLiverSimvastatinReperfusion Injury030211 gastroenterology & hepatologySurgerybusinessReperfusion injurymedicine.drugBMC surgery
researchProduct

Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Mod…

2010

The aim of this study is to assess the long-term effect of mesenchymal stem cells (MSC) transplantation in a rat model of chronic myocardial infarction (MI) in comparison with the effect of bone marrow mononuclear cells (BM-MNC) transplant. Five weeks after induction of MI, rats were allocated to receive intramyocardial injection of 106 GFP-expressing cells (BM-MNC or MSC) or medium as control. Heart function (echocardiography and 18F-FDG-microPET) and histological studies were performed 3 months after transplantation and cell fate was analyzed along the experiment (1 and 2 weeks and 1 and 3 months). The main findings of this study were that both BM-derived populations, BM-MNC and MSC, ind…

medicine.medical_specialtyTime FactorsAngiogenesisMyocardial InfarctionBiomedical Engineeringlcsh:Medicine030204 cardiovascular system & hematologyMesenchymal Stem Cell TransplantationPeripheral blood mononuclear cellTimeRats Sprague-DawleyAndrology03 medical and health sciences0302 clinical medicineInternal medicinemedicineAnimalsRegenerationChronic myocardial infarctionCells CulturedCardiac remodelingBone Marrow Transplantation030304 developmental biologyStem cell transplantation for articular cartilage repair0303 health sciencesTransplantationBone marrow stem cellsVentricular Remodelingbusiness.industryMyocardiumlcsh:RMesenchymal stem cellBone Marrow Stem CellCell BiologyRatsEndothelial stem cellTransplantationDisease Models AnimalTreatment Outcomemedicine.anatomical_structureChronic DiseaseCardiologyFemaleAngiogenesisBone marrowbusinessCell Transplantation
researchProduct

Use of Marginal Donors in Kidney Transplantation: Our Experience

2006

The use of elderly donors has been advocated to expand the organ donor pool because of increased needs and the organ shortage. The aim of this study was to analyze whether the use of elderly donors and marginal kidneys affected the outcome of renal transplantations. Herein we presented data on 126 kidney transplantations performed from January 1996 to September 2003 using 32 marginal donors (group A) and 94 ideal donors (group B). We analyzed the medical and surgical complications and the graft survivals at a median follow-up of 18 months. Medical and surgical complications occurred in 22% and 5% versus 7% and 4% in groups A and B, respectively. The mean cold ischemia time and the mean age …

medicine.medical_specialtyTime FactorsWaiting ListsEconomic shortageelderly patientsCold Ischemia TimeGroup BPostoperative ComplicationsCadaverHumansMedicineDonor poolKidney transplantationMarginal donorRetrospective StudiesTransplantationKidneybusiness.industryGraft SurvivalMean agemedicine.diseaseKidney TransplantationTissue DonorsSurgeryTreatment Outcomemedicine.anatomical_structureItalySurgeryGraft survivalbusinessFollow-Up StudiesTransplantation Proceedings
researchProduct

Influence of cold ischemia time on complement activation, neopterin, and cytokine release in liver transplantation.

2004

The aim of this study was to determine whether a cold ischemia time (CIT) of12 hours influences the activation of complement as well as the plasma concentrations of neopterin, interleukin (IL)-6, or IL-8 in orthotopic liver transplantation (OLT).Eighteen consecutive patients undergoing OLT using a veno-venous bypass technique were divided into 2 groups: duration of CIT12 hours (group 1; n = 11), and CIT12 hours (group 2; n = 7). Blood samples were drawn preoperatively, 1 minute before, and 120 minutes after reperfusion.Preoperatively, complement split products, neopterin, IL-6, and IL-8 levels did not differ between the groups. At 120 minutes after reperfusion, the concentrations of C3a, SC…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentIschemiaLiver transplantationGastroenterologyCold Ischemia TimeNeopterinchemistry.chemical_compoundIschemiaInternal medicinemedicineHumansComplement ActivationTransplantationbusiness.industryInterleukinsNeopterinInterleukinOrgan PreservationHypothermiamedicine.diseaseComplement systemLiver TransplantationTransplantationCold Temperaturesurgical procedures operativechemistryLiverImmunologyCytokinesSurgerymedicine.symptombusinessTransplantation proceedings
researchProduct

A score model for the continuous grading of early allograft dysfunction severity

2014

Early allograft dysfunction (EAD) dramatically influences graft and patient outcomes. A lack of consensus on an EAD definition hinders comparisons of liver transplant outcomes and management of recipients among and within centers. We sought to develop a model for the quantitative assessment of early allograft function [Model for Early Allograft Function Scoring (MEAF)] after transplantation. A retrospective study including 1026 consecutive liver transplants was performed for MEAF score development. Multivariate data analysis was used to select a small number of postoperative variables that adequately describe EAD. Then, the distribution of these variables was mathematically modeled to assig…

medicine.medical_specialtyTime Factorsmedicine.medical_treatmentLiver transplantationModels BiologicalSeverity of Illness IndexDecision Support TechniquesLiver diseasePredictive Value of TestsRisk FactorsInternal medicineSeverity of illnessmedicineHumansInternational Normalized RatioBlood CoagulationProportional Hazards ModelsRetrospective StudiesPrincipal Component AnalysisTransplantationHepatologyProportional hazards modelbusiness.industryGraft SurvivalReproducibility of ResultsAlanine TransaminaseBayes TheoremBilirubinRetrospective cohort studyClinical Enzyme Testsmedicine.diseaseLiver TransplantationSurgeryTransplantationTreatment OutcomeNonlinear DynamicsPredictive value of testsMultivariate AnalysisSurgeryLiver functionPrimary Graft DysfunctionbusinessBiomarkersLiver Transplantation
researchProduct

Should kidney allografts from old donors be allocated only to old recipients?

2020

Contains fulltext : 226016.pdf (Publisher’s version ) (Closed access) In several deceased donor kidney allocation systems, organs from elderly donors are allocated primarily to elderly recipients. The Eurotransplant Senior Program (ESP) was implemented in 1999, and since then, especially in Europe, the use of organs from elderly donors has steadily increased. The proportion of ≥60-year-old donors reported to the Collaborative Transplant Study (CTS) by European centers has doubled, from 21% in 2000-2001 to 42% in 2016-2017. Therefore, in the era of organ shortage it is a matter of debate whether kidney organs from elderly donors should only be allocated to elderly recipients or whether <65-y…

medicine.medical_specialtyTissue and Organ ProcurementMedizinEconomic shortage030230 surgeryKidneyold donors03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusIncreased creatininemedicineHumanskidney allograftsAgedDeceased donor kidneyKidneyTransplantationbusiness.industryGraft SurvivalAge FactorsCancerMiddle Agedmedicine.diseaseAllograftsKidney TransplantationTissue DonorsEuropekidney allografts ; old donors ;Marginal donormedicine.anatomical_structureDonation030211 gastroenterology & hepatologyRenal disorders Radboud Institute for Health Sciences [Radboudumc 11]business
researchProduct

Multiple brown tumours of tertiary hyperparathyroidism in a renal transplant recipient: : a case report

2010

Tertiary Hyperparathyroidism (HPT) is an uncommon condition that affects patients with secondary HPT after a successful kidney transplant. Bone alterations are the main consequences of this endocrine condition, including the development of an osteolytic lesion called brown tumour. This paper reports an unusual case of multiple brown tumours located in the maxilla and mandible in a 58-year-old renal transplant recipient, with tertiary HPT. Incisional biopsies were performed and, in both samples, the histopathological diagnoses were giant cell lesions. Due to these diagnoses, the medical history of chronic renal failure, and high levels of serum calcium and PTH, lesions were diagnosed as mult…

medicine.medical_specialtyTotal parathyroidectomyBone NeoplasmsTertiary hyperparathyroidismOrgan transplantationNeoplasms Multiple PrimarymedicineEndocrine systemHumansMedical historyGeneral Dentistrybusiness.industryHyperparathyroidismMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Jaw NeoplasmsKidney TransplantationSurgeryOtorhinolaryngologyRenal transplantGiant cellMaxillaUNESCO::CIENCIAS MÉDICASSurgeryFemalebusiness
researchProduct